Why the study?
The optimal postprocedural antithrombotic medical therapy to prevent recurrence of pulmonary vein stenosis after angioplasty is not known.
Does triple antithrombotic therapy reduce recurrence of pulmonary vein stenosis in patients undergoing PV angioplasty after atrial fibrillation ablation compared to dual therapy?
Comparison
Triple therapy vs dual therapy/DAPT
Design
Two-center retrospective study
Follow-up
3, 6, and 12 months (or 500 days)
Authors
Loading...
Optimal antithrombotic regimen after PV angioplasty remains undefined; leaves open need for prospective trials to reduce PVS recurrence.
Does triple antithrombotic therapy reduce recurrence of pulmonary vein stenosis in patients undergoing PV angioplasty after atrial fibrillation ablation compared to dual therapy?
Triple antithrombotic therapy after pulmonary vein angioplasty for post-ablation stenosis is associated with significantly lower rates of restenosis compared to dual therapy, without an apparent increase in severe bleeding.
Fink et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: